ROCHESTER—OptimizeRx Corp. (Nasdaq: OPRX), the Rochester-based provider of digital communication services for pharmaceutical companies to patients and healthcare providers, has announced a proposed underwritten public offering of shares of its common stock. The company sold 1,538,500 shares of its common stock at a price of $13 per share. The proceeds of the offering, before deducting
ROYAL OAK - Tember Shea, Portfolio Manager for Invest Detroit Ventures, interviews Mike Klein, CEO of Genomenon, to discuss the latest news coming out of the Ann Arbor-based gene therapy company. Mike Klein To listen, click on https://soundcloud.com/mike-brennan-841872555/e170-genomenon
TROY – A group of Michigan doctors is hosting an all-day forum June 8 in an effort to bridge the conversational gap between healthcare providers, patients and the cannabis industry to provide evidence supporting cannabis’ medical efficacy. “For those interested in gaining knowledge and resources regarding the medical benefits of cannabis, it will be extremely
ANN ARBOR—Genomenon Inc., the Ann Arbor-based genomics research information provider, has announced a partnership with Google to make the company’s genomic mutation data available on Google Cloud platform. Genomenon’s Cited Variants Reference (CVR) data will be a public dataset available in BigQuery, Google Cloud’s big data and machine learning data warehouse, for use in genomic applications. The
ROCHESTER—OptimizeRx Corp., the digital health messaging provider for the pharmaceutical industry, announced its latest platform integration with the health care industry’s leading acute electronic health record (EHR) systems, including Epic and Cerner. This latest announcement is a reflection of the company’s continued investment in hospitals and health systems, also emphasized in the latest company hiring
GRAND RAPIDS — The Michigan Department of Environmental Quality announced that it will sample 49 residential drinking water wells along Trout Creek in the neighborhood east of the 36th Street exits off I-96 and west of Tricklewood Drive for per- and polyfluoroalkyl substances (PFAS) as part of its ongoing investigation of potential PFAS contamination sources
ANN ARBOR – Wild bees are indispensable pollinators, supporting both agricultural productivity and the diversity of flowering plants worldwide. But wild bees are experiencing widespread declines resulting from multiple interacting factors. A new University of Michigan-led study suggests that the effects of one of those factors—urbanization—may have been underestimated. The team found that the sex
CANTON – TrialAssure, which developers clinical trial software tools, has released a new product, Anonymize DS, a Software-as-a-Service application that allows sponsors to anonymize clinical trial data automatically. TrialAssure Anonymize DS: · transforms original data into anonymized data using industry-standard techniques that can be reused and customized for each dataset · assigns a risk score
LIVONIA — Officials at Hygieia, the Livonia-based digital insulin guidance software developer, announced that the company has received clearance from the U.S. Food and Drug Administration for a phone app that will enhance the company’s d-Nav Insulin Guidance Service. The app is cleared for use as an aid in optimizing insulin management among people with
ROYAL OAK - Invest Detroit Ventures Tember Shea interviews portfolio company Javier Evelyn, Founder & CEO of Alerje, which is developing a low-cost epinephrine pen that is housed on the back of a smart phone. The healthcare startup has raised $300,000 so far and hopes to raise another round in seven figures this summer. Javier
